Baxter International (BAX) EBITDA Margin Growth (3y) (2012 - 2026)
Baxter International (BAX) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 7,391.00 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 722.00 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1,105.00 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 800.00 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -368.00 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -1,384.00 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -1,411.00 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -51.00 |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -284.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -284.00 |
| Mar 31, 2025 | -237.00 |
| Dec 31, 2024 | 3,404.00 |
| Sep 30, 2024 | 2,237.00 |
| Jun 30, 2024 | 2,458.00 |
| Mar 31, 2024 | -573.00 |
| Dec 31, 2023 | 1,091.00 |
| Sep 30, 2023 | -1,778.00 |
| Jun 30, 2023 | -1,283.00 |
| Mar 31, 2023 | -931.00 |
| Dec 31, 2022 | -2,597.00 |
| Sep 30, 2022 | -9,744.00 |
| Jun 30, 2022 | -500.00 |
| Mar 31, 2022 | -994.00 |
| Dec 31, 2021 | -1,300.00 |
| Sep 30, 2021 | 207.00 |
| Jun 30, 2021 | 28.00 |
| Mar 31, 2021 | -288.00 |
| Dec 31, 2020 | 238.00 |
| Sep 30, 2020 | 473.00 |